Platelet transfusion refractoriness due to graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation.
Taaning
E
E
Department of Clinical Immunology, State University Hospital, Rigshospitalet, Copenhagen, Denmark.
Jacobsen
N
N
D016824:Antigens, Human Platelet / Q000276:immunology*; D016026:Bone Marrow Transplantation / Q000276:immunology*; D005260:Female; D006680:HLA Antigens / Q000097:blood; D006650:Histocompatibility Testing; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood*; D007518:Isoantibodies / Q000097:blood*; D015470:Leukemia, Myeloid, Acute / Q000628:therapy; D008297:Male; D017713:Platelet Transfusion; D014184:Transplantation, Homologous
C071221:2b alloantigen, human; D016824:Antigens, Human Platelet; D006680:HLA Antigens; D007074:Immunoglobulin G; D007518:Isoantibodies